Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.
Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Sorensen HT, Stochholm K, Strasburger C, Swerdlow A, Thorner M. Allen DB, et al. Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12. Eur J Endocrinol. 2016. PMID: 26563978 Free PMC article.
Growth hormone: health considerations beyond height gain.
Ross J, Czernichow P, Biller BM, Colao A, Reiter E, Kiess W; advisory panel meeting on the effects of growth hormone. Ross J, et al. Pediatrics. 2010 Apr;125(4):e906-18. doi: 10.1542/peds.2009-1783. Epub 2010 Mar 22. Pediatrics. 2010. PMID: 20308212 Review.
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
Sävendahl L, Maes M, Albertsson-Wikland K, Borgström B, Carel JC, Henrard S, Speybroeck N, Thomas M, Zandwijken G, Hokken-Koelega A. Sävendahl L, et al. J Clin Endocrinol Metab. 2012 Feb;97(2):E213-7. doi: 10.1210/jc.2011-2882. Epub 2012 Jan 11. J Clin Endocrinol Metab. 2012. PMID: 22238393
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. Deal CL, et al. J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. J Clin Endocrinol Metab. 2013. PMID: 23543664 Free PMC article. Review.
Early recognition of growth abnormalities permitting early intervention.
Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W; Global Advisory Panel Meeting on the Effects of Growth Hormone. Haymond M, et al. Acta Paediatr. 2013 Aug;102(8):787-96. doi: 10.1111/apa.12266. Epub 2013 May 13. Acta Paediatr. 2013. PMID: 23586744 Free PMC article. Review.
Personalized approach to growth hormone treatment: clinical use of growth prediction models.
Wit JM, Ranke MB, Albertsson-Wikland K, Carrascosa A, Rosenfeld RG, Van Buuren S, Kristrom B, Schoenau E, Audi L, Hokken-Koelega AC, Bang P, Jung H, Blum WF, Silverman LA, Cohen P, Cianfarani S, Deal C, Clayton PE, de Graaff L, Dahlgren J, Kleintjens J, Roelants M. Wit JM, et al. Horm Res Paediatr. 2013;79(5):257-70. doi: 10.1159/000351025. Epub 2013 May 28. Horm Res Paediatr. 2013. PMID: 23735882 Free article.
360 results